Alignment Healthcare, Inc. (NASDAQ:ALHC) President Sells $4,393,000.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 230,000 shares of the company’s stock in a transaction dated Monday, April 14th. The stock was sold at an average price of $19.10, for a total transaction of $4,393,000.00. Following the completion of the transaction, the president now owns 2,132,899 shares of the company’s stock, valued at approximately $40,738,370.90. This trade represents a 9.73 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Dawn Christine Maroney also recently made the following trade(s):

• On Thursday, March 27th, Dawn Christine Maroney sold 11,152 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.89, for a total value of $199,509.28.
• On Wednesday, March 19th, Dawn Christine Maroney sold 16,535 shares of Alignment Healthcare stock. The stock was sold at an average price of $16.40, for a total value of $271,174.00.
• On Monday, March 17th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.99, for a total value of $479,700.00.
• On Wednesday, March 12th, Dawn Christine Maroney sold 27,243 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.43, for a total value of $420,359.49.
• On Thursday, March 6th, Dawn Christine Maroney sold 278,917 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.53, for a total transaction of $4,331,581.01.
• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.72, for a total transaction of $411,600.00.

Alignment Healthcare Stock Down 6.4 %

NASDAQ ALHC opened at $18.24 on Friday. The business’s fifty day simple moving average is $16.46 and its 200-day simple moving average is $13.79. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The firm has a market cap of $3.50 billion, a PE ratio of -23.69 and a beta of 1.32. Alignment Healthcare, Inc. has a 52 week low of $4.90 and a 52 week high of $21.06.

Analysts Set New Price Targets

ALHC has been the topic of a number of research reports. Stephens reaffirmed an “overweight” rating and issued a $17.00 price target on shares of Alignment Healthcare in a research note on Monday, February 24th. Barclays raised their target price on Alignment Healthcare from $8.00 to $9.00 and gave the company an “underweight” rating in a research report on Friday, February 28th. Stifel Nicolaus increased their price objective on Alignment Healthcare from $18.00 to $23.00 and gave the company a “buy” rating in a research note on Tuesday, April 8th. William Blair restated an “outperform” rating on shares of Alignment Healthcare in a report on Friday, February 28th. Finally, Piper Sandler upped their target price on shares of Alignment Healthcare from $14.00 to $21.00 and gave the stock an “overweight” rating in a report on Tuesday, March 4th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $16.61.

Hedge Funds Weigh In On Alignment Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of ALHC. Assenagon Asset Management S.A. raised its position in shares of Alignment Healthcare by 478.0% during the 1st quarter. Assenagon Asset Management S.A. now owns 831,397 shares of the company’s stock valued at $15,481,000 after buying an additional 687,566 shares during the period. Rhumbline Advisers increased its stake in Alignment Healthcare by 4.4% during the first quarter. Rhumbline Advisers now owns 141,638 shares of the company’s stock worth $2,637,000 after acquiring an additional 5,934 shares during the last quarter. GAMMA Investing LLC raised its position in Alignment Healthcare by 3,216.9% in the first quarter. GAMMA Investing LLC now owns 23,815 shares of the company’s stock valued at $443,000 after purchasing an additional 23,097 shares during the period. Wellington Management Group LLP lifted its stake in shares of Alignment Healthcare by 77.9% in the 4th quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company’s stock valued at $83,683,000 after purchasing an additional 3,257,630 shares during the last quarter. Finally, Mackenzie Financial Corp grew its holdings in shares of Alignment Healthcare by 149.8% during the 4th quarter. Mackenzie Financial Corp now owns 85,175 shares of the company’s stock worth $958,000 after purchasing an additional 51,084 shares during the period. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.